Will Tesla Go Up or Down in 2025?
The last few months have been exciting for Tesla and…
Buy
55
BXMX Quote, Financials, Valuation and Earnings
Last price:
$13.96
Seasonality move
:
-0.14%
Day range:
$13.89 - $14.06
52-week range:
$12.45 - $14.30
Dividend yield:
0.8%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
97.3K
Avg. volume:
166.4K
1-year change:
9.4%
Market cap:
--
Revenue:
$242.2M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNuveen S&P 500 Buy-Write Income Fund has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Nuveen S&P 500 Buy-Write Income Fund has an estimated downside of -- from its current price of $13.96.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $13.96.
Fair Value
-
According to the consensus of 0 analysts, Nuveen S&P 500 Buy-Write Income Fund has -- downside to fair value with a price target of -- per share.
BXMX vs. S&P 500
-
Over the past 5 trading days, Nuveen S&P 500 Buy-Write Income Fund has overperformed the S&P 500 by 2.41% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nuveen S&P 500 Buy-Write Income Fund does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nuveen S&P 500 Buy-Write Income Fund has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Nuveen S&P 500 Buy-Write Income Fund reported revenues of --.
Earnings Growth
-
Nuveen S&P 500 Buy-Write Income Fund has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Nuveen S&P 500 Buy-Write Income Fund reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-29 | 2023-12-29 | 2023-12-29 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.8M | $955.7K | $1.2M | $20.7M | $31.4M | |
| Total Assets | $1.3B | $1.6B | $1.4B | $1.5B | $1.6B | |
| Current Liabilities | $32.5M | $21.7M | $23.7M | $33.9M | $25.5M | |
| Total Liabilities | $61.9M | $52.9M | $41.9M | $76M | $56.3M | |
| Total Equity | $1.3B | $1.5B | $1.3B | $1.4B | $1.5B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-29 | 2023-12-29 | 2023-12-29 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
BXMX
Sector
Market Cap
--
--
Price % of 52-Week High
97.62%
--
Dividend Yield
0.8%
--
Shareholder Yield
--
--
1-Year Price Total Return
9.4%
--
Beta (5-Year)
0.877
--
Dividend yield:
0.8%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$13.84
200-day SMA
Buy
Level
$13.41
Bollinger Bands (100)
Buy
Level
13.37 - 13.97
Chaikin Money Flow
Buy
Level
8.8M
20-day SMA
Sell
Level
$14.01
Relative Strength Index (RSI14)
Buy
Level
50.97
ADX Line
Sell
Level
20.08
Williams %R
Neutral
Level
-38.6364
50-day SMA
Buy
Level
$13.89
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
27.6M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options strategy of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.
Stock Forecast FAQ
In the current month, BXMX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BXMX average analyst price target in the past 3 months is --.
-
Where Will Nuveen S&P 500 Buy-Write Income Fund Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nuveen S&P 500 Buy-Write Income Fund share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Nuveen S&P 500 Buy-Write Income Fund?
Analysts are divided on their view about Nuveen S&P 500 Buy-Write Income Fund share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nuveen S&P 500 Buy-Write Income Fund is a Sell and believe this share price will rise from its current level to --.
-
What Is Nuveen S&P 500 Buy-Write Income Fund's Price Target?
The price target for Nuveen S&P 500 Buy-Write Income Fund over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BXMX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nuveen S&P 500 Buy-Write Income Fund is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BXMX?
You can purchase shares of Nuveen S&P 500 Buy-Write Income Fund via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nuveen S&P 500 Buy-Write Income Fund shares.
-
What Is The Nuveen S&P 500 Buy-Write Income Fund Share Price Today?
Nuveen S&P 500 Buy-Write Income Fund was last trading at $13.96 per share. This represents the most recent stock quote for Nuveen S&P 500 Buy-Write Income Fund. Yesterday, Nuveen S&P 500 Buy-Write Income Fund closed at $13.96 per share.
-
How To Buy Nuveen S&P 500 Buy-Write Income Fund Stock Online?
In order to purchase Nuveen S&P 500 Buy-Write Income Fund stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
